By Josh White
Date: Wednesday 03 Sep 2025
(Sharecast News) - Ondine Biomedical said in an update on Wednesday that its health economic analysis of Steriwave nasal photodisinfection would be presented at the 12th International Conference on Prevention & Infection Control (ICPIC) in Geneva after being selected for an oral session at the event.
By Josh White
Date: Wednesday 13 Aug 2025
(Sharecast News) - Ondine Biomedical announced Wednesday that it will pilot its Steriwave nasal photodisinfection system at ABC Medical Center in Mexico City from September, marking the technology's first hospital deployment in Mexico.
By Josh White
Date: Monday 21 Jul 2025
(Sharecast News) - Ondine Biomedical announced the completion of a landmark 291-patient clinical study using its Steriwave nasal photodisinfection technology in the intensive care unit at Royal Columbian Hospital in British Columbia on Monday, marking the first such study in critically ill ICU patients globally.
| Currency | UK Pounds |
| Share Price | 12.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 18.00p |
| 52 Week Low | 7.38p |
| Volume | 130,000 |
| Shares Issued | 518.37m |
| Market Cap | £64.80m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 17:08 | 40,000 @ 12.50p |
| 11:09 | 50,000 @ 12.28p |
| 09:59 | 40,000 @ 12.95p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research